Report: Breast cancer screening program (The Netherlands): Difference between revisions
From Beacon
No edit summary |
m (Update categories.) |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forpolicymakers</span> | |||
<span style="display:none">thenetherlandscountry</span> | |||
Go back to [[The Netherlands]] page | Go back to [[The Netherlands]] page | ||
| Line 14: | Line 15: | ||
'''Access to information:''' [https://iknl.nl/getmedia/b9e6bc9b-a5d8-4b25-a915-9e6b1d1d67bd/national-monitoring-breast-cancer-screening-in-the-Netherlands-2020-2021.pdf Click here to access]. | '''Access to information:''' [https://iknl.nl/getmedia/b9e6bc9b-a5d8-4b25-a915-9e6b1d1d67bd/national-monitoring-breast-cancer-screening-in-the-Netherlands-2020-2021.pdf Click here to access]. | ||
<span style="display:none">Lobular</span> | |||
<span style="display:none">Breast</span> | |||
<span style="display:none">Nipple</span> | |||
<span style="display:none">Areola</span> | |||
<span style="display:none">Ductal</span> | |||
<span style="display:none">dataOwner::Integraal Kankercentrum Nederland</span> | |||
<span style="display:none">availableVariable::screening</span> | |||
<span style="display:none">availableVariable::cancer incidence</span> | |||
<span style="display:none">availableVariable::number of deaths</span> | |||
<span style="display:none">availableVariable::year</span> | |||
<span style="display:none">dataLevel::national level</span> | |||
<span style="display:none">isReport</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">Axilla</span> | |||
<span style="display:none">Axillary</span> | |||
<span style="display:none">Mammary</span> | |||
Latest revision as of 12:09, 14 December 2025
Go back to The Netherlands page
Primary purpose: To detect breast cancer early, leading to better prognosis, and it is coordinated by the RIVM, with annual monitoring by IKNL to ensure program quality and identify trends and bottlenecks.
Sponsor, manager or home institution: Integraal Kankercentrum Nederland.
Type of information: screening, cancer incidence, number of deaths, year. The number screened in the reporting year; Invitations, participation rate and referrals; Incidence and mortality rates. Click here to learn more.
Data level: national level.
Cancer areas of interest: C50: Breast cancer. Click here to learn more.
Access to information: Click here to access.
